Characterisation of Epstein-Barr virus-specific memory T cells from the peripheral blood of seropositive individuals.

[1]  C. Doré,et al.  RHEUMATOID LYMPHOCYTE DEFECT REVEALED BY CYCLOSPORIN A , 1982, The Lancet.

[2]  J. H. Pope,et al.  Generation in vitro of HLA‐restricted EB virus‐specific cytotoxic human T cells by autologous lymphoblastoid cell lines: The roles of previous EB virus infection and foetal calf serum , 1982, International journal of cancer.

[3]  S. Ferrone,et al.  T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells. , 1981, Journal of immunology.

[4]  J. Sosman,et al.  Functional analysis of human T cell subsets defined by monoclonal antibodies. III. Regulation of helper factor production by T cell subsets. , 1981, Journal of immunology.

[5]  G. Möller,et al.  Cyclosporin A blocks receptors for HLA-DR antigens on T cells , 1981, Nature.

[6]  S. McLachlan,et al.  Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines , 1981, Nature.

[7]  M. Epstein,et al.  HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells , 1980, Nature.

[8]  J. H. Pope,et al.  Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytes , 1978, International journal of cancer.

[9]  E. Yunis,et al.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens , 1978, The Journal of experimental medicine.

[10]  M. E. Kaplan,et al.  An improved rosetting assay for detection of human T lymphocytes. , 1974, Journal of immunological methods.

[11]  W. Henle,et al.  Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis. , 1973, The Journal of infectious diseases.

[12]  H. D. Golden,et al.  Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. , 1973, The Journal of infectious diseases.

[13]  G. Klein,et al.  The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV , 1971, International journal of cancer.

[14]  A. Evans,et al.  Seroepidemiologic studies of infectious mononucleosis with EB virus. , 1968, The New England journal of medicine.

[15]  R. Callard,et al.  Phenotype of human T helper and suppressor cells in an in vitro specific antibody response , 1982, European journal of immunology.

[16]  M. Epstein,et al.  Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro , 1981, European journal of immunology.

[17]  M. Epstein.  Epstein-Barr virus--discovery, properties and relationship to nasopharyngeal carcinoma. , 1978, IARC scientific publications.